Benefits of Living Over Deceased Donor Kidney Transplantation in Elderly Recipients. A Propensity Score Matched Analysis of a Large European Registry Cohort

Transpl Int. 2024 Aug 23:37:13452. doi: 10.3389/ti.2024.13452. eCollection 2024.

Abstract

Although kidney transplantation from living donors (LD) offers better long-term results than from deceased donors (DD), elderly recipients are less likely to receive LD transplants than younger ones. We analyzed renal transplant outcomes from LD versus DD in elderly recipients with a propensity-matched score. This retrospective, observational study included the first single kidney transplants in recipients aged ≥65 years from two European registry cohorts (2013-2020, n = 4,257). Recipients of LD (n = 408), brain death donors (BDD, n = 3,072), and controlled cardiocirculatory death donors (cDCD, n = 777) were matched for donor and recipient age, sex, dialysis time and recipient diabetes. Major graft and patient outcomes were investigated. Unmatched analyses showed that LD recipients were more likely to be transplanted preemptively and had shorter dialysis times than any DD type. The propensity score matched Cox's regression analysis between LD and BDD (387-pairs) and LD and cDCD (259-pairs) revealing a higher hazard ratio for graft failure with BDD (2.19 [95% CI: 1.16-4.15], p = 0.016) and cDCD (3.38 [95% CI: 1.79-6.39], p < 0.001). One-year eGFR was higher in LD transplants than in BDD and cDCD recipients. In elderly recipients, LD transplantation offers superior graft survival and renal function compared to BDD or cDCD. This strategy should be further promoted to improve transplant outcomes.

Keywords: deceased donor; elderly renal transplant; living donor; propensity score analysis; survival.

Publication types

  • Observational Study

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Europe
  • Female
  • Graft Rejection
  • Graft Survival*
  • Humans
  • Kidney Transplantation* / statistics & numerical data
  • Living Donors*
  • Male
  • Propensity Score*
  • Registries*
  • Retrospective Studies
  • Tissue Donors
  • Treatment Outcome

Grants and funding

The authors declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by the European Union (ERDF/ESF)- A way to build Europe (grant numbers PI19/01710; PI23/01909; AC21_2/00050; AC22/00029). and co-funded by the RICORS (Redes de Investigación Cooperativa Orientadas a Resultados en Salud) consortia by the Instituto de Salud Carlos III.